Clinical Trial Update: A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 study comparing steady-state bioavailability of injectable Letrozole SIE versus oral Letrozole in postmenopausal women with hormone receptor-positive ea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Letrozole injectable SIE (letrozole)

Snippet

Sponsor: Rovi Pharmaceuticals Laboratories | Conditions: Hormone Receptor Positive Early Breast Cancer | Phase 1 | Status: NOT_YET_RECRUITING